WALTHAM, Mass.--(BUSINESS WIRE)--Avila Therapeutics, Inc. a biotechnology company developing targeted covalent drugs that treat diseases through protein silencing, announced that Katrine Bosley, Avila’s Chief Executive Officer, is scheduled to present a corporate update at the 10th Annual Needham Healthcare Conference, on Wednesday, April 6, 2011 at 1:40 p.m. ET at the New York Palace Hotel.
